Dermot Reilly retweeted
Exercise may be the single most potent medical intervention ever known. Its benefits in prevention outstrip any known drugs: 50% reduction in the risk of cardiovascular disease, 50% reduction in the risk of many cancers, positive effects on mental health, pulmonary health, GI health, bone health, muscle function. You name it. Exercise helps. In fact, the ability to exercise over long distances was likely key to our evolution as a species because the availability of densely caloric foods due to persistence hunting allowed our energy-avid brains to enlarge. And yet, we have had very little insight into the molecular basis of these magical effects...until now!
Published in yesterday's Nature and featured on the cover was work from our consortium that represents the culmination of a couple of decades of pitching ideas to the NIH, forming a consortium, planning experiments, executing those experiments, and analyzing data at unprecedented scale, all aimed at enhancing our understanding of the molecular transducers of exercise.
It was a major effort from so many in our consortium (playfully named MoTrPAC) and is the first landmark paper of many more to come. This first paper focused on the multi-tissue, multi-omics of treadmill exercise in rats. Specifically, we report the effects of eight weeks of treadmill running on the transcriptome, the epigenome, the proteome, the metabolome, the lipidome and the immunome of a broad range of tissues (in fact, 9,466 assays across 19 tissues, 25 molecular platforms, and 4 training time points).
The result is the most comprehensive molecular map of exercise ever created. At Stanford, my colleague @MWheelerMD and I co-lead the bioinformatics center and it was our team's duty and privilege to ingest the data, QC the data, help analyze the data, and make the data available to the world. Various tools available at our data hub allow you to explore the data, visualize it, and download it for your own use.
Have fun! And stay tuned for human data that will be coming.
So many people to thank who made this possible (see the paper for details). Special shout out to the primary analysts and authors: David Amar, Nicole Gay, & Pierre Jean Baltran.
Paper: nature.com/articles/s41586-0…
Data hub: motrpac-data.org/
Dermot Reilly retweeted
Is having even more gene-disease associations still useful for picking drug targets?
For which types of programs does it matter?
Has pharma shifted focus towards genetically validated targets?
New paper by me, @mnelsonxy, @DongCoco90417, & @jivecast doi.org/10.1101/2023.06.23.2…👇
Dermot Reilly retweeted
Adjusting for common variants improves the power of rare variant association tests. An expected result under the liability threshold model, but great to see an empirical demo through a systematic analysis. 👏👏
@JurgensSean @patrick_ellinor @jpirruccello
nature.com/articles/s41588-0…
I’m currently hiring a postdoctoral scientist in Kidney Disease Discovery Biology based in Boston, MA at Janssen Pharmaceuticals (J&J) in the Cardiovascular, Metabolism, Retinal & Pulmonary Hypertension (CVMRPH) Therapeutic Area. 1/
Publication of the results of the research will be a key goal of this postdoctoral research program. Interested candidates are welcome to reach out to me for additional information and are encouraged to submit an application on the J&J careers site. 4/
1
1
#hiring #pharmaceuticals #kidneydisease #discovery #postdoc Postdoctoral Scientist, Kidney Disease Discovery Biology # 2206074647W [Boston, MA]
jobs.jnj.com/jobs/2206074647…
5/
3
Dermot Reilly retweeted
🎇Our massive effort to define genes and cells causing kidney disease published @NatureGenet by @Hongbo919Liu New GWAS in 1.5 million, kidney eQTL in 686, meQTL 443, snATACseq 60K cells, coloc, moloc, MR, pheWAS to prioritize >500 genes for kidney disease go.nature.com/3tHf9Lj
Dermot Reilly retweeted
Very excited to share our new 1M single cell atlas of diabetic kidney disease and its treatment (including SGLT2i!) in @Cell_Metabolism led by the amazing @HaojiaWu and in close collaboration with Matt Breyer & team a 🧵! 1/12
sciencedirect.com/science/ar…
I’m currently recruiting a Bioinformatics and a Genetics Sr Scientist role within the CVMR Integrative Sciences group at Janssen. We are a team of translational bioinformaticians that intersect multi-omic data and human biology to better understand disease processes and discover
motivated and collaborative computational biologists and geneticists with a passion for discovery. Join us!
Please review the roles below and submit an application via the J&J Careers site.
1
1
Senior Scientist - Discovery, Bioinformatics Analyst # 2206044014W [Spring House, PA]
jobs.jnj.com/jobs/2206044014…
Senior Scientist - Discovery, Genetics/Statistical Genetics # 2206043995W [Boston, MA]
jobs.jnj.com/jobs/2206043995…
1
Dermot Reilly retweeted
We celebrate the AMP® Program – Type 2 Diabetes, a public-private collaboration led by @FNIH_Org. The partnership set a precedent in data sharing in human genetics and the T2D knowledge portal has become a model for research in other diseases.
Watch: youtu.be/KtMeKEXKcAU
Dermot Reilly retweeted
New from @connoremdin!
Genetics of cirrhosis — 8K cases | 424K controls
New stats gen method identifies 7 new variants, including ApoE4 protective variant
Gene-env interaction: alcohol unmasks high genetic risk of cirrhosis
https://teapawt.org/t.co/GJp1JtAQxG
kheralab.org/publications
Dermot Reilly retweeted
Our genetic study of the electrocardiogram is published in Cell Systems. A long-time goal of mine was to analyse the electrocardiogram in an unbiased manner and visualise the impact of genetics on the ECG, which we did here cell.com/cell-systems/fullte…
Dermot Reilly retweeted
Thrilled to share our study in @NatureGenet on large-scale GWAS in a Japanese population, together with @masato__AKIYAMA, @soumya_boston, Yoichiro Kamatani, and many fantastic colleagues! All summary stats are available for everyone!
nature.com/articles/s41588-0…
Dermot Reilly retweeted
Editorial: A landmark study will help pinpoint candidate disease-causing genetic mutations and find new drug targets in the human genome. But it also highlights the challenges in making these data sets more representative of the world’s population. go.nature.com/3gycprB
Dermot Reilly retweeted
Our review of recent past & near future of human disease genetics (1990-2030) has just been published in Nature (nature.com/articles/s41586-0…). Thanks to co-authors too numerous to list, & to @obahcall et al at Nature (including the reviewers) for pulling this together. #humgen25 1/n
















